CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Retained Earnings (Accumulated Deficit) [Member]	Total
Balances at Dec. 31, 2010	$ 64,382	$ 57,888,506	$ (25,000)	$ (51,827,360)	$ 6,100,528
Balances (in shares) at Dec. 31, 2010	64,381,910
Employee share-based compensation expense	0	809,469	0	0	809,469
Other share-based compensation expense	0	222,208	0	0	222,208
Exercise of stock options	25	(22)	0	0	3
Exercise of stock options (in shares)	25,000
Sale of common stock and warrants (net of $600 of offering costs)	3,634	3,629,087	0	0	3,632,721
Sale of common stock and warrants (net of $600 of offering costs) (in shares)	3,633,321
Shares issued in conjunction with conversion of convertible debt	406	406,257	0	0	406,663
Shares issued in conjunction with conversion of convertible debt (in shares)	406,664
Shares issued in conjunction with acquisition of Surgical Biologics, LLC	5,250	7,082,250	0	0	7,087,500
Shares issued in conjunction with acquisition of Surgical Biologics, LLC (in shares)	5,250,000
Beneficial conversion feature recognized on convertible debt	0	437,500	0	0	437,500
Discount on beneficial conversion feature recognized on line of credit	0	80,000	0	0	80,000
Net loss for the peiod	0	0	0	(5,851,067)	(5,851,067)
Balances at Jun. 30, 2011	$ 73,697	$ 70,555,255	$ (25,000)	$ (57,678,427)	$ 12,925,525
Balances (in shares) at Jun. 30, 2011	73,696,895